Latest Breaking News On - Avutometinib defactinib - Page 1 : comparemela.com

Premal Thaker, MD, MS, discusses how the RAMP-201 trial paved a way for the RAMP-301 trial of avutometinib/defactinib in low-grade serous ovarian cancer.

United statesSiteman cancer centerPremal thakerGynecologic oncology clinical researchDivision of gynecologic oncologyLynn mutch distinguished professorGynecologic oncologyRamp 201 trialRamp 301 trialAvutometinib defactinibLow grade serous ovarian cancer